Zobrazeno 1 - 10
of 291
pro vyhledávání: '"C. Bouffioux"'
Publikováno v:
International Journal of Mechanical Sciences. 235:107723
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
W. Oosterlinck, A. P. M. Van Der Meijden, Maurizio Brausi, Richard Sylvester, Karl-Heinz Kurth, C. Bouffioux
Publikováno v:
European Urology. 37:1-9
Objective: The therapeutic objectives in the initial treatment of superficial tumors are to remove completely the tumor, to assess the need for further therapy and to plan the follo
Autor:
C. Bouffioux, A. Pawinski, L. Bijnens, Richard Sylvester, Karl-Heinz Kurth, M.K.B. Parmar, A. P. M. Van der Meijden
Publikováno v:
Journal of Urology. 156:1934-1941
Purpose: The use of prophylactic agents after primary resection can decrease the incidence of tumor recurrence in patients with stage TaT1 bladder cancer. However, the long-term impact on progression to muscle invasive disease as well as on duration
Publikováno v:
BJU International. 77:634-637
Autor:
Kh Kurth, Richard Sylvester, Fmj Debruyne, Michele Pavone-Macaluso, Willem Oosterlinck, L. Denis, C. Bouffioux
Publikováno v:
European Journal of Cancer. 31:1840-1846
Prognostic factors in superficial bladder tumours are highly correlated with each other. In this study, their relative importance is examined and grouping of patients in three different prognostic groups suggested. 576 patients (from EORTC protocols
Autor:
Karl-Heinz Kurth, Aldo V. Bono, M. De Pauw, C. Boeken Kruger, Richard Sylvester, W. Oosterlinck, C. Bouffioux
Publikováno v:
The Journal of Urology. :934-941
The European Organization for Research and Treatment of Cancer genitourinary group has completed 2 parallel prospective randomized studies, one with 30 mg. mitomycin C and the other with 50 mg. doxorubicin as adjuvant intravesical treatment after tra
Autor:
W. Oosterlinck, C. Boeken Kruger, C. Bouffioux, Aldo V. Bono, M. De Pauw, Richard Sylvester, Karl-Heinz Kurth
Publikováno v:
Journal of Urology. 153:934-941
The European Organization for Research and Treatment of Cancer genitourinary group has completed 2 parallel prospective randomized studies, one with 30 mg.mitomycin C and the other with 50 mg. doxorubicin as adjuvant intravesical treatment after tran
Autor:
M. Pavone-Macaluso, D.Di Trapani, C. Pavone, F. Piaia, F. Rocco, L. Denis, C. Bouffioux, H. de Voogt, T. Becopoulos, D. Newling, P.H. Smith, M.R.G. Robinson
Publikováno v:
Scandinavian Journal of Urology and Nephrology. 25:77-82
Autor:
C, Bouffioux
Publikováno v:
Scandinavian Journal of Urology and Nephrology. 25:167-177